Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Neurology
Orla Gray has not added Biography.
If you are Orla Gray and would like to personalize this page please email our Author Liaison for assistance.
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry.
Journal of neurology, neurosurgery, and psychiatry Mar, 2012 | Pubmed ID: 22205675
Increasing age at disability milestones among MS patients in the MSBase Registry.
Journal of the neurological sciences Jul, 2012 | Pubmed ID: 22507751
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon Beta 1a dosages for multiple sclerosis.
PloS one , 2013 | Pubmed ID: 23704913
Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) Jan, 2014 | Pubmed ID: 24107309
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
Brain : a journal of neurology Dec, 2013 | Pubmed ID: 24142147
Risk of relapse phenotype recurrence in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) Oct, 2014 | Pubmed ID: 24777276
Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.
Annals of neurology Dec, 2014 | Pubmed ID: 25283272
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) Aug, 2015 | Pubmed ID: 25480857
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.
PloS one , 2015 | Pubmed ID: 26046348
Symptomatic therapy in multiple sclerosis: Big pharma should do more - NO.
Multiple sclerosis (Houndmills, Basingstoke, England) Jul, 2015 | Pubmed ID: 26084348
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) Jul, 2015 | Pubmed ID: 26199347
Defining reliable disability outcomes in multiple sclerosis.
Brain : a journal of neurology Nov, 2015 | Pubmed ID: 26359291
Ulster Hospital
Tim Spelman1,2,
Orla Gray3,
Robyn Lucas4,
Helmut Butzkueven1,2
1Department of Neurology, Royal Melbourne Hospital,
2Department of Medicine (RMH), The University of Melbourne,
3Department of Neurology, Ulster Hospital,
4National Centre for Epidemiology and Population Health, Australian National University
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.